Such an example may be illustrated by the recent discovery of LKB1, inactivated in a variety of cancers, as an activator of p114RhoGEF-driven junction assembly, which occurs via recruitment by cingulin and PATJ junctional adaptors. Here, ARHGEF18 is linked to cancer.